Beyond market averages, investors seeking exceptional growth focus on the art of stock selection. The right picks can significantly contribute to the expansion of your wealth.
As of close of business last night, GT Biopharma Inc’s stock clocked out at $0.94, up 1.72% from its previous closing price of $0.93. In other words, the price has increased by $1.72 from its previous closing price. On the day, 2.59 million shares were traded. GTBP stock price reached its highest trading level at $0.95 during the session, while it also had its lowest trading level at $0.893.
Ratios:
To gain a deeper understanding of GTBP’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 2.76 and its Current Ratio is at 2.76. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, ROTH MKM on December 02, 2024, initiated with a Buy rating and assigned the stock a target price of $11.
On May 24, 2021, H.C. Wainwright started tracking the stock assigning a Buy rating and target price of $25. On April 13, 2021, B. Riley Securities started tracking the stock assigning a Buy rating and target price of $21.B. Riley Securities initiated its Buy rating on April 13, 2021, with a $21 target price.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, GTBP now has a Market Capitalization of 3361837 and an Enterprise Value of 90839.
Stock Price History:
The Beta on a monthly basis for GTBP is 1.39, which has changed by -0.56511736 over the last 52 weeks, in comparison to a change of 0.18469036 over the same period for the S&P500. Over the past 52 weeks, GTBP has reached a high of $4.10, while it has fallen to a 52-week low of $0.88. The 50-Day Moving Average of the stock is -49.42%, while the 200-Day Moving Average is calculated to be -59.80%.
Shares Statistics:
It appears that GTBP traded 104.37K shares on average per day over the past three months and 434460 shares per day over the past ten days. A total of 3.27M shares are outstanding, with a floating share count of 3.04M. Insiders hold about 14.60% of the company’s shares, while institutions hold 9.80% stake in the company. Shares short for GTBP as of 1755216000 were 260999 with a Short Ratio of 2.50, compared to 1752537600 on 273519. Therefore, it implies a Short% of Shares Outstanding of 260999 and a Short% of Float of 7.4200004.
Earnings Estimates
The stock of GT Biopharma Inc (GTBP) is currently drawing attention from 1.0 analysts actively involved in the ongoing evaluation and rating process.The consensus estimate for the next quarter is -$0.21, with high estimates of -$0.21 and low estimates of -$0.21.
Analysts are recommending an EPS of between -$1.31 and -$1.31 for the fiscal current year, implying an average EPS of -$1.31. EPS for the following year is -$0.62, with 1.0 analysts recommending between -$0.62 and -$0.62.
